American Journal of Obstetrics & Gynecology
Volume 201, Issue 5 , Pages 488.e1-488.e7 , November 2009

Value of p16INK4a as a marker of progression/regression in cervical intraepithelial neoplasia grade 1

  • Marta del Pino, MD

      Affiliations

    • Department of Obstetrics and Gynecology, IDIBAPS-Hospital Clínic, University of Barcelona Faculty of Medicine, Barcelona, Spain
    • ,
  • Sònia Garcia, MD

      Affiliations

    • Department of Obstetrics and Gynecology, IDIBAPS-Hospital Clínic, University of Barcelona Faculty of Medicine, Barcelona, Spain
    • ,
  • Victòria Fusté, MD

      Affiliations

    • Department of Pathology, IDIBAPS-Hospital Clínic, University of Barcelona Faculty of Medicine, Barcelona, Spain
    • ,
  • Immaculada Alonso, MD

      Affiliations

    • Department of Obstetrics and Gynecology, IDIBAPS-Hospital Clínic, University of Barcelona Faculty of Medicine, Barcelona, Spain
    • ,
  • Pere Fusté, MD

      Affiliations

    • Department of Obstetrics and Gynecology, IDIBAPS-Hospital Clínic, University of Barcelona Faculty of Medicine, Barcelona, Spain
    • ,
  • Aureli Torné, MD

      Affiliations

    • Department of Obstetrics and Gynecology, IDIBAPS-Hospital Clínic, University of Barcelona Faculty of Medicine, Barcelona, Spain
    • ,
  • Jaume Ordi, MD

      Affiliations

    • Department of Pathology, IDIBAPS-Hospital Clínic, University of Barcelona Faculty of Medicine, Barcelona, Spain

Received 24 December 2008 ,Revised 12 February 2009 ,Accepted 26 May 2009.

References 

  1. el Hamidi A, Kocjan G, Du MQ. Clonality analysis of archival cervical smears: correlation of monoclonality with grade and clinical behavior of cervical intraepithelial neoplasia. Acta Cytol. 2003;47:117–123
  2. Schneider V. CIN prognostication: will molecular techniques do the trick?. Acta Cytol. 2003;47:115–116
  3. Wright TC, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189:295–304
  4. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 66 (Management of abnormal cervical cytology and histology). Obstet Gynecol. 2005;106:645–664
  5. Cox JT, Schiffman M, Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188:1406–1412
  6. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186–192
  7. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293–299
  8. Schiffman M, Khan MJ, Solomon D, et al. A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst. 2005;97:147–150
  9. Ordi J, Garcia S, del Pino M, et al. p16INK4a Immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol. 2009;28:90–97
  10. Giarre M, Caldeira S, Malanchi I, Ciccolini F, Leao MJ, Tommasino M. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle. Arrest J Virol. 2001;75:4705–4712
  11. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:1741–1748
  12. von Knebel DM. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer. 2002;38:2229–2242
  13. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276–284
  14. Negri G, Egarter-Vigl E, Kasal A, Romano F, Haitel A, Mian C. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol. 2003;27:187–193
  15. Ozalp SS, Yalcin OT, Tanir HM, Dundar E, Yildirim S. Bcl-2 expression in preinvasive and invasive cervical lesions. Eur J Gynaecol Oncol. 2002;23:419–422
  16. Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol. 2007;31:33–43
  17. Ordi J, Alonso I, Torne A, et al. Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test?. Gynecol Oncol. 2005;99:313–319
  18. Hariri J, Oster A. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynecol Pathol. 2007;26:223–228
  19. Negri G, Vittadello F, Romano F, et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch. 2004;445:616–620
  20. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol. 2003;16:665–673
  21. Schorge JO, Lea JS, Elias KJ, et al. P16 as a molecular biomarker of cervical adenocarcinoma. Am J Obstet Gynecol. 2004;190:668–673
  22. Tringler B, Gup CJ, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol. 2004;35:689–696
  23. Santos M, Montagut C, Mellado B, et al. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol. 2004;23:206–214
  24. Santos M, Landolfi S, Olivella A, et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol. 2006;30:1347–1356
  25. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159:1211–1218
  26. Lu DW, El-Mofty SK, Wang HL. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol. 2003;16:692–699
  27. Klussmann JP, Weissenborn SJ, Wieland U, et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?. Med Microbiol Immunol. 2003;192:129–132
  28. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367–1372
  29. Guimaraes MC, Goncalves MA, Soares CP, Bettini JS, Duarte RA, Soares EG. Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions. J Histochem Cytochem. 2005;53:509–516
  30. Guo M, Hu L, Baliga M, He Z, Hughson MD. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2004;122:894–901
  31. Hu L, Guo M, He Z, Thornton J, McDaniel LS, Hughson MD. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol. 2005;18:267–273
  32. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389–1399
  33. Hilfrich R, Hariri J. Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker. Anal Quant Cytol Histol. 2008;30:78–82
  34. Negri G, Bellisano G, Zannoni GF, et al. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri. Am J Surg Pathol. 2008;32:1715–1720
  35. Youkeles L, Forsythe AB, Stern E. Evaluation of Papanicolaou smear and effect of sample biopsy in follow-up of cervical dysplasia. Cancer Res. 1976;36:2080–2084

 Cite this article as: del Pino M, Garcia S, Fusté V, et al. Value of p16INK4a as a marker of progression/regression in cervical intraepithelial neoplasia grade 1. Am J Obstet Gynecol 2009;201:488.e1-7.

 Reprints not available from the authors.

PII: S0002-9378(09)00557-2

doi: 10.1016/j.ajog.2009.05.046

American Journal of Obstetrics & Gynecology
Volume 201, Issue 5 , Pages 488.e1-488.e7 , November 2009

Article Tools

* Image Usage & Resolution